Home > News > 68/Fusion pacing optimization with MultiPoint pacing in cardiac resynchronization therapy improves dyssynchrony of myocardial activation, an electrocardiographic imaging assessment
Arrhythmia
Read Time: < 1 min

68/Fusion pacing optimization with MultiPoint pacing in cardiac resynchronization therapy improves dyssynchrony of myocardial activation, an electrocardiographic imaging assessment

Published Online: September 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr68
Authors: PH Waddingham (Presenting Author) - St Bartholomew’s Hospital, Barts Health NHS Trust, London; M Orini - St Bartholomew’s Hospital, Barts Health NHS Trust, London; J Mangual - Abbott, Sylmar; A Muthumala - St Bartholomew’s Hospital, Barts Health NHS Trust, London; S Sporton - St Bartholomew’s Hospital, Barts Health NHS Trust, London; PD Lambiase - St Bartholomew’s Hospital, Barts Health NHS Trust, London; AWC Chow - St Bartholomew’s Hospital, Barts Health NHS Trust, London
Quick Links:
Article
Article Information
Article:

Background: Cardiac resynchronization therapy (CRT) with MultiPoint Pacing (MPP) can improve electrical resynchronization of the left ventricle (LV) compared to conventional CRT. The SyncAV™ algorithm dynamically combines intrinsic atrioventricular (AV) conduction with pacing, improving electrical synchrony. The study objectives included assessment of the change in electrical synchrony with SyncAV and MPP, using non-invasive mapping with electrocardiographic imaging (ECGi).

Methods: Patients with LBBB (QRSd ≥150 ms), in sinus rhythm, scheduled for CRT device (MPP enabled CRT P/D, quadripolar LV lead) implantation underwent ECGi acutely. Mapping was done during intrinsic rhythm, nominal AV delay (140/110ms paced/sensed) and optimized SyncAV (individualized SyncAV offset minimizing QRSd) during: biventricular (BiV) and MultiPoint pacing (MPP). BiV activation time (AT) duration and AT dispersion on the LV (LVED=coefficient of variation of AT) were calculated.

Results: ECGi mapping was completed in 10 patients (80% male, mean age 66.4±16 years, 60% ischaemic, LVEF 30±6%, intrinsic QRSd 167±15ms) following SyncAV optimization. Compared to intrinsic conduction (AT: 136.1±15.8ms, LVED: 22.4±3.6%), AT duration was reduced using BiV SyncAV (104.2±20.4ms, p=0.027), MPP nominal (105.1±17.1ms, p=0.023) and MPP SyncAV (96.7±20.2ms, p=0.001); LVED was reduced only by MPP SyncAV (12.1±4.4ms, p=0.008). With respect to BiV nominal (119.0±31.2ms) MPP SyncAV reduced both AT duration (p=0.049) and LVED (12.1±4.4ms, p=0.049).

Conclusions: The duration and dispersion of LV activation may be reduced incrementally by SyncAV and MPP, whereas the combination of MPP and SyncAV achieved significant improvements in the dyssynchrony of activation.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
Arrhythmia
43/Cardiac tamponade as a complication of transseptal puncture: associations and operatordependent variables during left atrial ablation at Barts Heart Centre
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; K Mahtani - St Bartholomew’s Hospital, London; C Butcher - St Bartholomew’s Hospital, London; N Ahluwalia - St Bartholomew’s Hospital, London; M Finlay - St Bartholomew’s Hospital, London; S Honarbakhsh - St Bartholomew’s Hospital, London; A Creta - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; V Sawhney - St Bartholomew’s Hospital, London; V Ezzat - St Bartholomew’s Hospital, London; MJ Earley - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; MD Lowe - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; SY Ahsan - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; O Sega - St Bartholomew’s Hospital, London Read Time: 2 mins

European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr43

Introduction: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the incidence and predictors of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our centre from 2016-2020. Methods: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinised to adjudicate TSP culpability. Adjusted multivariate […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72